MITRA — Mithra Pharmaceuticals SA Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 96.5 | 9.03 | 22.7 | 67 | 40.2 |
Cost of Revenue | |||||
Gross Profit | 94 | 5.57 | 6.94 | 47.4 | 18.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 69.5 | 92.7 | 111 | 93.2 | 179 |
Operating Profit | 27 | -83.7 | -87.9 | -26.2 | -139 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -31.4 | -111 | -124 | -11.5 | -162 |
Provision for Income Taxes | |||||
Net Income After Taxes | -26.6 | -92.1 | -117 | -59.6 | -174 |
Net Income Before Extraordinary Items | |||||
Net Income | -26.6 | -92.1 | -117 | -59.6 | -174 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -26.6 | -92.1 | -117 | -59.6 | -174 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.704 | -2.19 | -2.69 | -1.22 | -1.81 |